About the Anticancer Agents Session
Anticancer agents encompass a diverse range of therapies designed to combat cancer by targeting specific aspects of tumor growth and metastasis. These agents can include chemotherapy drugs, targeted therapies, immunotherapies, and hormone therapies. Chemotherapy drugs, such as cisplatin and paclitaxel, work by interfering with the cell division process, effectively killing rapidly dividing cancer cells. Targeted therapies, like monoclonal antibodies and small molecule inhibitors, aim to disrupt specific molecules or pathways crucial for cancer cell survival and proliferation. Immunotherapies harness the power of the immune system to recognize and eliminate cancer cells. Hormone therapies are effective against hormone-sensitive cancers by blocking hormone receptors or reducing hormone production. The development of novel anticancer agents continues to revolutionize cancer treatment, offering hope for improved outcomes and enhanced quality of life for patients.
Topics Covered in Anticancer Agents
Alkylating Agents
Antimetabolites
Microtubule Inhibitors
Topoisomerase Inhibitors
Hormonal Agents
Immunomodulatory Agents
Related Scientific Sessions at CIOC 2027
Why Attend the Anticancer Agents Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Anticancer Agents work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Anticancer Agents research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Anticancer Agents track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Anticancer Agents Conference 2027 — FAQs
What is the Anticancer Agents track at CIOC 2027?
The Anticancer Agents track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Anticancer Agents. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Anticancer Agents sessions?
Cancer researchers and clinicians, educators and students with an interest in Anticancer Agents are all welcome — whether presenting or attending.
Can I present my research in the Anticancer Agents track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Anticancer Agents sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Anticancer Agents track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.